Strengthening the local partner network in the UAE through a large-scale stakeholder eventTargeting value-driven consumers and driving expansion in the UAE with 'Laufenn' a brand by...
BRISBANE, Australia, June 5, 2026 /PRNewswire/ -- Allianz Partners today announced it has signed an agreement to acquire a large portion of nib's Australian...
Faith in Music Foundation Grant Helps Independent Artist Counter Culture of Nihilism Through Electronic Dance MusicORLANDO, Fla., June 4, 2026 /PRNewswire/ -- Grammy-winning artist Kaya...
Files Amended Form 10 Registration StatementAnnounces Scheduling Details for Resideo and ADI Investor DaysReaffirms Previously Announced Second Quarter and Full Year 2026 Outlook; Releases...
Telly Awards Follow Four Consecutive 'Best Journalism Film' at the International Motor Film AwardsTRAVERSE CITY, Mich., June 4, 2026 /PRNewswire/ -- Hagerty, Inc. (NYSE: HGTY)...
SYDNEY, June 4, 2026 /PRNewswire/ -- Shoplazza, a global AI-native eCommerce platform, is helping Australian merchants move faster from product idea to online store...
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).